Nan Jiang

Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development

Qingjie Ding, Zhuming Zhang, Jinjun Liu et al. · Journal of Medicinal Chemistry · 2013 · 583 citations · Full text

Drug Target, Chemical Biology, Cancer Biology +19

Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development

Binh Thanh Vu, Peter M. Wovkulich, Giacomo Pizzolato et al. · ACS Medicinal Chemistry Letters · 2013 · 373 citations · Full text

Drug Target, Cell Death, Small-molecule Mdm2 Inhibitor +17

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings

Dao-zhen Xu, Xuanyi Wang, Xinliang Shen et al. · Journal of Hepatology · 2013 · 149 citations

Vaccination, Hepatitis D, Viral Hepatitis +7

Pigmented Villonodular Synovitis: A Retrospective Multicenter Study of 237 Cases

Guo-Ping Xie, Nan Jiang, Changxiang Liang et al. · PLoS ONE · 2015 · 133 citations · Full text

Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity

Xin‐Jie Chu, Wanda DePinto, David Bartkovitz et al. · Journal of Medicinal Chemistry · 2006 · 116 citations · Full text

Drug Target, Pharmacotherapy, Cell Cycle +17